1. 1108PCan concomitant diseases predict the compliance with cisplatin plus RT in patients with LA SCCHN? An exploratory endpoint analysis of the COMPLY trial. (23rd October 2018) Authors: Dunst, J; Hildebrandt, G; Becker-Schiebe, M; Kuhnt, T; Weykamp, F; Martucci, F; Vordermark, D; Pless, M; Hofmann, D; Bühler, V; Rothschild, S I Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II. (23rd August 2018) Authors: Dietz, A; Wichmann, G; Kuhnt, T; Pfreundner, L; Hagen, R; Scheich, M; Kölbl, O; Hautmann, M G; Strutz, J; Schreiber, F; Bockmühl, U; Schilling, V; Feyer, P; de Wit, M; Maschmeyer, G; Jungehülsing, M; Schroeder, U; Wollenberg, B; Sittel, C; Münter, M Journal: Annals of oncology Issue: Volume 29:Number 10(2018) Page Start: 2105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O-011Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12. (2nd July 2019) Authors: Hofheinz, R; Fokas, E; Allgäuer, M; Polat, B; Klautke, G; Grabenbauer, G; Fietkau, R; Kuhnt, T; Staib, L; Brunner, T; Grosu, A; Schmiegel, W; Jacobasch, L; Weitz, J; Folprecht, G; Germer, C; Grützmann, R; Schwarzbach, M; Bechstein, W; Friede, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗